Nils Asmann, Brenda Kischkel, Leo A.B. Joosten. Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk. // Current Opinion in Pharmacology. – 2026. – DOI: 10.1016/j.coph.2026.102664. – URL: https://doi.org/10.1016/j.coph.2026.102664
Nils Asmann, Brenda Kischkel, & Leo A.B. Joosten (2026). Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2026.102664
Nils Asmann, et al. “Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk.” Current Opinion in Pharmacology, 2026. doi:10.1016/j.coph.2026.102664.
@article{Asmann2026,
title = {Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk},
author = {Asmann, Nils and Kischkel, Brenda and Joosten, Leo A.B.},
journal = {Current Opinion in Pharmacology},
year = {2026},
doi = {10.1016/j.coph.2026.102664},
url = {https://doi.org/10.1016/j.coph.2026.102664}
}